Cambium/xylem-preferred promoters and uses thereof

Details for Australian Patent Application No. 2010201471 (hide)

Owner Alellyx S.A.

Inventors Papes, Fabio; Gerhardt, Isabel Rodrigues; Arruda, Paulo

Agent Griffith Hack

Pub. Number AU-B-2010201471

Parent 2005230212

Filing date 14 April 2010

Wipo publication date 6 May 2010

Acceptance publication date 5 April 2012

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A01H 5/00 (2006.01) Products

C12N 5/14 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Plant cells

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

Event Publications

29 April 2010 Complete Application Filed

6 May 2010 Application Open to Public Inspection

  Published as AU-B-2010201471

5 April 2012 Application Accepted

  Published as AU-B-2010201471

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010201472-Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents

2010201470-An Improved Merchandise Unit